Q1 FY22 Results: Mytheresa Reports Strong GMV Growth of 29.7% in Q1 FY22 and Continued Strong Profitability
MYT Netherlands Parent B.V. (NYSE: MYTE) reported strong financial results for Q1 FY22, ending September 30, 2021. Gross Merchandise Value (GMV) rose by 29.7% year-over-year, reaching €163.9 million, and net sales increased by 24.9% to €157.8 million. The company achieved a gross profit margin of 49.0% and adjusted EBITDA of €14.0 million, a growth of 34.4% compared to the previous year. Mytheresa expects continued growth with a projected net sales range of €700 million to €720 million for the full fiscal year.
- GMV growth of 29.7% year-over-year to €163.9 million.
- Net sales increased by 24.9% to €157.8 million.
- Adjusted EBITDA rose by 34.4% to €14.0 million.
- Strong gross profit margin of 49.0%.
- Active customer base growth of 35.2%, reaching 705,000.
- None.
-
Gross Merchandise Value (GMV) growth of
29.7% to€163.9 million in Q1 FY22, compared to€126.4 million in Q1 FY21 -
Top-line strength evident by two-year GMV growth of
65.3% in Q1 FY22 vs. Q1 FY20 -
Strong gross profit margin of
49.0% , as compared to46.4% in Q1 FY21 -
Continued strong profitability with adjusted EBITDA of
€14.0 million compared to€10.4 million in Q1 FY21, representing strong growth of34.4% -
Increase of adjusted EBITDA margin to
8.9% from8.3% in Q1 FY21
Kliger continued, "The shift of consumer demand to online in luxury has clearly accelerated in recent months. We strongly believe this trend will continue in the post-pandemic world, probably reverting to the strong market growth rates we had seen before the pandemic. We will continue to deliver a superior customer experience and deepen our partnerships with the most coveted global brands. Given our strong financial momentum, excellent customer developments, and superior execution, we feel extremely confident to continue achieving strong results for full fiscal year 2022.”
FINANCIAL HIGHLIGHTS FOR THE FIRST QUARTER ENDED
-
GMV increase of
29.7% year-over-year to€163.9 million , as compared to€126.4 million in the prior year period -
Net sales increase of
24.9% year-over-year to€157.8 million -
Strong gross profit margin of
49.0% , as compared to46.4% in the prior year period -
Adjusted EBITDA of
€14.0 million , as compared to€10.4 million in the prior year period -
Adjusted operating income of
€11.8 million , as compared to€8.4 million in the prior year period -
Adjusted net income of
€8.2 million , as compared to€5.4 million in the prior year period
RECENT BUSINESS HIGHLIGHTS
Strong Global Expansion:
-
Strong GMV growth across all geographies with +
29.7% vs. Q1 FY21 and +65.3% vs. Q1 FY20 -
Strongest net sales growth in
the United States with +48.7% vs. Q1 FY21 as market presence continues to grow -
High-impact top customers events in
Europe ,China andthe United States
Continued Brand Partnerships:
-
Exclusive capsule collections and pre-launches in collaboration with
Saint Laurent , Gucci, The Row,Christian Louboutin ,Tom Ford , Chloé and many more - “Money-can’t buy” physical brand experiences together with Givenchy and Tod’s
- Successful start of Curated Platform Model (CPM) with first major brand partner
High-quality Customer Growth:
-
LTM growth of active customers by
35.2% reaching 705,000 - Continued strong repurchase rates of new customer cohorts in FY21 vs. FY20
-
Strong growth of number of top customers with
41.0% in Q1 FY22 vs. Q1 FY21 -
Successful roll-out and expansion of new partnership with
Vestiaire Collective offering a unique resale service for Mytheresa’s high-end luxury customers
Consistent Strong Operational Performance:
-
Maintained business continuity across all operations with focus on health and well-being of all
Mytheresa employees as top priority - Introduced animal welfare policy and carbon neutrality as of Q1 FY22
-
Continued to have very high customer satisfaction with a Net Promoter Score of
83.0% in Q1 FY22 - Achieved strong gross profit margin based on high full-price share of sales
BUSINESS OUTLOOK
For the full fiscal year ending
-
GMV in the range of
€750 million to€770 million , representing a22% to25% growth -
Active customer growth of
22% to25% , enlarging the customer base to 820,000 to 845,000 active customers -
Net sales at
€700 million to€720 million -
Gross profit at
€345 million to€355 million , representing a21% to24% growth -
Adjusted EBITDA margin at the upper half of the long term range of
7% to9%
The foregoing forward-looking statements reflect Mytheresa’s expectations as of today's date. Given the number of risk factors, uncertainties and assumptions discussed below, actual results may differ materially.
CONFERENCE CALL AND WEBCAST INFORMATION
FORWARD LOOKING STATEMENTS
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements relating to the impact of the COVID-19 global pandemic; future sales, expenses, and profitability; future development and expected growth of our business and industry; our ability to execute our business model and our business strategy; having available sufficient cash and borrowing capacity to meet working capital, debt service and capital expenditure requirements for the next twelve months; and projected capital spending. In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements are only predictions. Actual events or results may differ materially from those stated or implied by these forward-looking statements. In evaluating these statements and our prospects, you should carefully consider the factors set forth below.
We undertake no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law.
The achievement or success of the matters covered by such forward-looking statements involves known and unknown risks, uncertainties and assumptions. If any such risks or uncertainties materialize or if any of the assumptions prove incorrect, our results could differ materially from the results expressed or implied by the forward-looking statements we make.
You should not rely upon forward-looking statements as predictions of future events. Forward-looking statements represent our management’s beliefs and assumptions only as of the date such statements are made.
Further information on these and other factors that could affect our financial results is included in filings we make with the
ABOUT NON-IFRS FINANCIAL MEASURES AND OPERATING METRICS
We review a number of operating and financial metrics, including the following business and non-IFRS metrics, to evaluate our business, measure our performance, identify trends affecting our business, formulate business plans and make strategic decisions. We present Adjusted EBITDA, Adjusted Operating Income and Adjusted Net Income because they are frequently used by analysts, investors and other interested parties to evaluate companies in our industry. Further, we believe these measures are helpful in highlighting trends in our operating results, because they exclude the impact of items that are outside the control of management or not reflective of our ongoing operations and performance. Adjusted EBITDA, Adjusted Operating Income, and Adjusted Net Income have limitations, because they exclude certain types of expenses. We use Adjusted EBITDA, Adjusted Operating Income, Adjusted Net Income as supplemental information only. You are encouraged to evaluate each adjustment and the reasons we consider it appropriate for supplemental analysis.
Our non-IFRS financial measures include:
-
Adjusted EBITDA is a non-IFRS financial measure that we calculate as net income before finance expense (net), taxes, and depreciation and amortization, adjusted to exclude
U.S. sales tax expenditures temporarily borne by us through the fourth quarter of fiscal year 2020, IPO preparation and transaction costs and share-based compensation expenses. -
Adjusted Operating Income is a non-IFRS financial measure that we calculate as operating income, adjusted to exclude
U.S. sales tax expenditures temporarily borne by us through the fourth quarter of fiscal year 2020, any IPO preparation and transaction costs and share-based compensation expenses. -
Adjusted Net Income is a non-IFRS financial measure that we calculate as net income, adjusted to exclude
U.S. sales tax expenditures temporarily borne by us, finance expenses on our Shareholder Loans, IPO preparation and transaction costs, share-based compensation expenses and related income tax effects.
We are not able to forecast net income (loss) on a forward-looking basis without unreasonable efforts due to the high variability and difficulty in predicting certain items that affect net income (loss), including, but not limited to, Income taxes and Interest expense and, as a result, are unable to provide a reconciliation to forecasted Adjusted EBITDA.
Gross Merchandise Value (GMV) means the total Euro value of orders processed. GMV is inclusive of merchandise value, shipping and duty. It is net of returns, value added taxes and cancellations. We view GMV as an operating metric.
ABOUT
For more information, please visit https://investors.mytheresa.com/.
Financial Results and Key Operating Metrics
(Amounts in € millions)
|
Three Months Ended |
||||
|
|
|
|
|
|
|
September 30, 2020 |
|
September 30, 2021 |
|
Change in % / BPs |
|
|
|
|
|
|
(in millions) (unaudited) |
|
|
|
|
|
Gross Merchandise Value (GMV) |
|
|
|
|
|
Active customer (LTM in thousands) |
522 |
|
705 |
|
|
Total orders shipped (LTM in thousands) |
1,168 |
|
1,580 |
|
|
|
|
|
|
|
|
Net sales |
|
|
|
||
Gross profit |
|
|
|
||
Gross profit margin(1) |
|
|
260 BPs |
||
Adjusted EBITDA(2) |
|
|
|
||
Adjusted EBITDA margin(1) |
|
|
60 BPs |
||
Adjusted Operating Income(2) |
|
|
|
||
Adjusted Operating Income margin(1) |
|
|
80 BPs |
||
Adjusted Net Income(2) |
|
|
|
||
Adjusted Net Income margin(1) |
|
|
90 BPs |
(1) |
As a percentage of net sales. |
(2) |
EBITDA, adjusted EBITDA, adjusted Operating Income, adjusted net income are measures not defined under IFRS. For further information about how we calculate these measures and limitations of its use, see above. |
Financial Results and Key Operating Metrics
(Amounts in € millions)
The following are reconciliations of Adjusted EBITDA, Adjusted Operating Income, and Adjusted Net Income to their most directly comparable IFRS financial measures:
|
Three Months Ended |
||||
|
|
|
|
|
|
|
September 30, 2020 |
|
September 30, 2021 |
|
Change in % |
|
|
|
|
|
|
(in millions) (unaudited) |
|
|
|
|
|
Net income |
|
|
|
|
( |
Finance expenses, net |
|
|
|
|
( |
Income tax expense |
|
|
|
|
( |
Depreciation and amortization |
|
|
|
|
|
thereof depreciation of right-of use assets |
|
|
|
|
|
EBITDA |
|
|
|
( |
|
IPO preparation and transaction costs(1) |
|
|
|
( |
|
IPO-related and preceding share-based compensation(2) |
|
|
|
N/A |
|
Adjusted EBITDA |
|
|
|
|
|
Three Months Ended |
||||
|
|
|
|
|
|
|
September 30, 2020 |
|
September 30, 2021 |
|
Change in % |
|
|
|
|
|
|
(in millions) (unaudited) |
|
|
|
|
|
Operating Income |
|
|
( |
||
IPO preparation and transaction costs(1) |
|
|
( |
||
IPO-related and preceding share-based compensation(2) |
|
|
N/A |
||
Adjusted Operating Income |
|
|
|
Financial Results and Key Operating Metrics
(Amounts in € millions)
|
Three Months Ended |
||||
|
|
|
|
|
|
|
September 30, 2020 |
|
September 30, 2021 |
|
Change in % |
|
|
|
|
|
|
(in millions) (unaudited) |
|
|
|
|
|
Net Income |
|
|
|
|
( |
IPO preparation and transaction costs(1) |
|
|
|
|
( |
IPO-related and preceding share-based compensation (2) |
|
|
|
|
N/A |
Finance expenses on shareholder loans (3) |
|
|
|
|
( |
Income tax effect(4) |
|
|
|
|
( |
Adjusted Net Income |
|
|
|
|
|
(1) |
Represents non-recurring professional fees, including consulting, legal and accounting fees, related to this offering, which are classified within selling, general and administrative expenses. |
(2) |
In fiscal 2021, with the effective IPO, certain key management personnel received a one-time granted share-based compensation, these expenses will be recognized upon defined vesting schedules in the future periods. We do not consider these expenses to be indicative of our core operating performance. |
(3) |
Our Adjusted Net Income excludes finance expenses associated with our Shareholder Loans, which we do not consider to be indicative of our core performance. We did not receive any cash proceeds under the Shareholder Loans, which originated as part of the |
(4) |
Reflects adjustments to historical income tax expense to reflect changes in taxable income for each of the periods presented due to changes in finance expenses related to the Shareholder Loans, assuming a statutory tax rate of |
Unaudited Condensed Consolidated Statements of Profit and Comprehensive Income
(Amounts in € thousands, except share and per share data)
|
|
Three Months Ended |
||
|
|
|
||
(in € thousands) |
|
|
|
|
|
|
|
|
|
Net sales |
|
126,359 |
|
157,832 |
Cost of sales, exclusive of depreciation and amortization |
|
(67,678) |
|
(80,516) |
Gross profit |
|
58,681 |
|
77,316 |
Shipping and payment cost |
|
(14,833) |
|
(19,966) |
Marketing expenses |
|
(17,441) |
|
(22,427) |
Selling, general and administrative expenses |
|
(15,556) |
|
(36,158) |
Depreciation and amortization |
|
(2,021) |
|
(2,182) |
Other expense (income), net |
|
(621) |
|
(281) |
Operating income |
|
8,209 |
|
(3,699) |
Finance income |
|
8,291 |
|
- |
Finance costs |
|
(3,109) |
|
(189) |
Finance income (costs), net |
|
5,182 |
|
(189) |
Income (loss) before income taxes |
|
13,391 |
|
(3,888) |
Income tax (expense) income |
|
(3,762) |
|
(3,408) |
Net income (loss) |
|
9,629 |
|
(7,296) |
Cash Flow Hedge |
|
871 |
|
(1,081) |
Income Taxes related to Cash Flow Hedge |
|
(242) |
|
267 |
Foreign currency translation |
|
- |
|
(25) |
Other comprehensive income (loss) |
|
629 |
|
(839) |
Comprehensive income (loss) |
|
10,258 |
|
(8,136) |
|
|
|
|
|
Basic and diluted earnings per share |
€ |
0.14 |
€ |
(0.09) |
Weighted average ordinary shares outstanding (basic and diluted) |
|
70,190,687 |
|
84,525,207 |
Unaudited Condensed Consolidated Statements of Financial Position
(Amounts in € thousands)
(in € thousands) |
|
|
||
Assets |
||||
Non-current assets |
||||
Intangible assets and goodwill |
155,611 |
155,482 |
||
Property and equipment |
|
8,810 |
|
8,459 |
Right-of-use assets |
14,009 |
22,710 |
||
Total non-current assets |
178,430 |
186,651 |
||
Current assets |
|
|
||
Inventories |
|
247,054 |
|
264,955 |
Trade and other receivables |
5,030 |
3,755 |
||
Other assets |
|
14,667 |
|
15,240 |
Cash and cash equivalents |
76,760 |
55,685 |
||
Total current assets |
|
343,510 |
|
339,635 |
Total assets |
521,941 |
526,286 |
||
|
|
|||
Shareholders’ equity and liabilities |
|
|
||
Subscribed capital |
1 |
1 |
||
Capital reserve |
|
444,951 |
|
461,086 |
Accumulated Deficit |
(60,837) |
(68,133) |
||
Other comprehensive income |
|
1,602 |
|
763 |
Total shareholders’ equity |
385,718 |
393,716 |
||
|
|
|||
Non-current liabilities |
|
|
|
|
Provisions |
|
717 |
|
734 |
Lease liabilities |
8,786 |
17,397 |
||
Deferred tax liabilities |
|
2,308 |
|
3,161 |
Total non-current liabilities |
11,811 |
21,292 |
||
Current liabilities |
|
|
|
|
Tax liabilities |
14,293 |
15,750 |
||
Lease liabilities |
|
5,361 |
|
5,459 |
Contract liabilities |
10,975 |
7,773 |
||
Trade and other payables |
|
43,558 |
|
27,222 |
Other liabilities |
50,225 |
55,073 |
||
Total current liabilities |
|
124,412 |
|
111,277 |
Total liabilities |
136,223 |
132,569 |
||
Total shareholders’ equity and liabilities |
|
521,941 |
|
526,286 |
Unaudited Condensed Consolidated Statements of Changes in Equity
(Amounts in € thousands)
(in € thousands) |
|
Subscribed capital |
|
Capital reserve |
|
Accumulated deficit |
|
Hedging reserve |
|
Foreign currency translation reserve |
|
Total shareholders’ equity |
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of |
|
1 |
|
91,008 |
|
(28,234) |
|
-
|
|
1,602 |
|
64,377 |
Net income |
|
- |
|
- |
|
6,350 |
|
- |
|
- |
|
6,350 |
Other comprehensive income |
|
- |
|
- |
|
- |
|
629 |
|
4,730 |
|
4,730 |
Comprehensive income |
|
- |
|
- |
|
6,350 |
|
629 |
|
4,730 |
|
11,080 |
Share-based compensation |
|
- |
7 |
- |
|
|
- |
7 |
||||
Balance as of |
|
1 |
|
91,015 |
|
(18,605) |
|
629 |
|
1,602 |
|
74,642 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of |
|
1 |
|
444,951 |
|
(60,837) |
|
- |
|
1,602 |
|
385,718 |
Net income |
|
- |
|
- |
|
(7,296) |
|
- |
|
- |
|
(7,296) |
Other comprehensive income |
|
- |
|
- |
|
- |
|
(814) |
|
(25) |
|
(839) |
Comprehensive income |
|
- |
|
- |
|
(7,296) |
|
(814) |
|
(25) |
|
(8,136) |
Share-based compensation |
|
- |
|
16,134 |
|
- |
|
- |
|
- |
|
16,134 |
Balance as of |
|
1 |
|
461,086 |
|
(68,133) |
|
(814) |
|
1,577 |
|
393,716 |
Unaudited Condensed Consolidated Statements of Cash Flows
(Amounts in € thousands)
|
Three Months ended |
|||
(in € thousands) |
|
2020 |
|
2021 |
|
|
|
|
|
Net income (loss) |
|
9,629 |
|
(7,296) |
Adjustments for |
|
|
|
|
Depreciation and amortization |
|
2,021 |
|
2,182 |
Finance (income) costs, net |
|
(5,182) |
|
189 |
Share-based compensation |
|
7 |
|
16,134 |
Income tax expense |
|
3,762 |
|
3,408 |
Change in operating assets and liabilities |
|
|
|
|
Increase in provisions |
|
129 |
|
17 |
Increase in inventories |
|
(33,328) |
|
(17,901) |
(Increase) decrease in trade and other receivables |
|
(970) |
|
1,274 |
Decrease (increase) in other assets |
|
1,980 |
|
(519) |
(Decrease) increase in other liabilities |
|
2,879 |
|
3,713 |
Increase (decrease) in contract liabilities |
|
600 |
|
(3,202) |
Increase (decrease) in trade and other payables |
|
(14,905) |
|
(16,336) |
Income taxes paid |
|
- |
|
(831) |
Net cash provided by (used in) operating activities |
|
(33,378) |
|
(19,166) |
Expenditure for property and equipment and intangible assets |
|
(904) |
|
(356) |
Net cash (used in) investing activities |
|
(904) |
|
(356) |
Interest paid |
|
(547) |
|
(189) |
Proceeds from bank liabilities |
|
37,810 |
|
- |
Repayment of liabilities from banks |
|
(5,000) |
|
- |
Payment of lease liabilities |
|
(1,429) |
|
(1,339) |
Net cash (used in) provided by financing activities |
|
30,834 |
|
(1,528) |
Net increase (decrease) in cash and cash equivalents |
|
(3,448) |
|
(21,050) |
Cash and cash equivalents at the beginning of the period |
|
9,367 |
|
76,760 |
Effects of exchange rate changes on cash and cash equivalents |
|
(19) |
|
(25) |
Cash and cash equivalents at end of the period |
|
5,900 |
|
55,685 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20211111005234/en/
Investor Relations
Solebury Trout
+1-800-929-7167
investors@mytheresa.com
Media for public relations
mobile: +49 152 54725178
phone: +49 89 127695-236
email: sandra.romano@mytheresa.com
Media for business press
mobile: +49 152 38297355
phone: +49 89 127695-1358
email: alberto.fragoso@mytheresa.com
Source:
FAQ
What were the financial results of MYT Netherlands Parent B.V. for Q1 FY22?
How did adjusted EBITDA perform for MYTE in Q1 FY22?
What is the gross profit margin reported by MYT for Q1 FY22?